Heritage Pharmaceuticals Etomidate Injection Recall: Subpotent Drug Risk
Heritage Pharmaceuticals recalls Etomidate Injection vials due to subpotent drug content. Affected vials have specific NDC and lot numbers. Consumers should contact the manufacturer for details.
Lower-risk recall
Subpotent Drug.
Contact the company
What happened, in plain English
Heritage Pharmaceuticals is recalling Etomidate Injection vials that may contain less active drug than labeled. This could lead to ineffective treatment if used as prescribed. The recall affects specific vial lots manufactured in India. Read more at govinfonow.com/recall/39189-heritage-pharmaceuticals-etomidate-injection-recall-subpotent-drug-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/39189-heritage-pharmaceuticals-etomidate-injection-recall-subpotent-drug-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1065-2019
Cite this page
“Heritage Pharmaceuticals Etomidate Injection Recall: Subpotent Drug Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39189-heritage-pharmaceuticals-etomidate-injection-recall-subpotent-drug-risk. Based on FDA recall #D-1065-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1065-2019%22&limit=1).
Why it’s dangerous
The vials contain a subpotent drug, meaning they have less active ingredient than labeled. This could result in the medication being less effective than intended during medical procedures. However, the risk of serious harm is not clearly described in the recall.
Who’s affected
Prescribers and patients who have received the recalled Etomidate Injection vials for medical use. Those using the vials for anesthesia or sedation are most at risk.
How to tell if you have this one
Check for NDC 23155-160-31 and lot numbers AMA701 (expiring March 2019) or AMA702/AMA703 (expiring August 2019). The vials are single-dose, 10 mL, for prescription use only.
- Brand
Heritage Pharmaceuticals- Category
Drug
What to do — step by step
Check Vial Details
Look for NDC 23155-160-31 and lot numbers AMA701, AMA702, or AMA703 on the vial.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Heritage Pharmaceuticals recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1065-2019 (February 15, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1065-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.